Nalaganje...
BOOP as a rare complication of gemcitabine therapy
Gemcitabine is commonly used in combination with carboplatin in patients with advanced non-small-cell lung cancer (NSCLC). Gemcitabine has good clinical activity against NSCLC and is well tolerated by the patients. Myelosuppression is its dose-limiting toxicity. A potential side effect of gemcitabin...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3143343/ https://ncbi.nlm.nih.gov/pubmed/22689600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr.04.2011.4055 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|